The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Vascular risk factors, cognitve decline, and dementia
Open accessAbstract
Dementia is one of the most important neurological disorders in the elderly. Aging is associated with a large increase in the prevalence and incidence of degenerative (Alzheimer's disease) and vascular dementia, leading to a devastating loss of autonomy. In view of the increasing longevity of populations worldwide, prevention of dementia has turned into a major public health challenge. In the past decade, several vascular risk factors have been found to be associated with vascular dementia but also Alzheimer's disease. Some longitudinal studies, have found significant associations between hypertension, diabetus mellitus, and metabolic syndrome, assessed at middle age, and dementia. Studies assessing the link between hypercholesterolemia, atrial fibrillation, smoking, and dementia have given more conflicting results. Furthermore, some studies have highlighted the possible protective effect of antihypertensive therapy on cognition and some trials are evaluating the effects of statins and treatments for insulin resistance. Vascular risk factors and their treatments are a promising avenue of research for prevention of dementia, and further long-term, placebo-controlled, randomized studies, need to be performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Reinprecht, F., Elmståhl, S., Janzon, L., & André-Petersson, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00014 · Cited by 49
Weight loss and metabolic changes in dementia.
Wang, S. Y. (2002) · PubMed · Cited by 48
Mooser, V., Helbecque, N., Miklossy, J., Marcovina, S. M., NICOD, P. H., & Amouyel, P. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00004 · Cited by 44
Dementia drug development: use of information systems to harmonize global drug development.
Whitehouse, P. J., Sciulli, C., & Mason, R. M. (1997) · PubMed · Cited by 42
Hanon, O., Latour, F., Ml, S., Lenoir, H., Forette, F., & As, R. (2005) · PubMed · Cited by 41
Self-citationOkumiya, K., Matsubayashi, K., Wada, T., Osaki, Y., Doi, Y., & Ozawa, T. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02981.x · Cited by 40
McGuinness, B., Todd, S., Passmore, P., & Bullock, R. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004034 · Cited by 40
The influence of smoking on the risk of Alzheimer's disease
Riggs, J. E., & Merchant, C. (2000) · Neurology · doi:10.1212/wnl.54.3.777-a · Cited by 37
beta-Amyloid vasoactivity in Alzheimer's disease.
Kalaria, R. N., & Hedera, P. (1996) · PubMed · Cited by 31
Blood pressure and cognitive decline in healthy old people
Starr, J., Deary, I. J., Inch, S., Cross, S. H., & Wj, M. (1997) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000551 · Cited by 30
Atorvastatin for the treatment of mild to moderate Alzheimer disease: Preliminary results
Santa, W. (2005) · Dkgest of the World Latest Medical Information · Cited by 26
Hypotension and cognitive impairment: Selective association in patients with heart failure
Sabatini, T., Barbisoni, P., Rozzini, R., & Trabucchi, M. (2002) · Neurology · doi:10.1212/wnl.59.7.1118-a · Cited by 25
Hsueh, W. A. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500383 · Cited by 15
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
Hulette, C. M., & Welsh-Bohmer, K. A. (2007) · Neurology · doi:10.1212/01.wnl.0000256286.78188.dd · Cited by 14
Cognitive impairment in congestive heart failure?: Embolism vs hypoperfusion
Rozzini, R., Barbisoni, P., & Trabucchi, M. (2019) · Cited by 5
Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study
Khachaturian, A. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.noc60013 · Cited by 3
Cited by
Jones, L., Holmans, P. A., Hamshere, M. L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013950 · Cited by 606
Cognitive Disorders and Dementia in CKD: The Neglected Kidney-Brain Axis
Bugnicourt, J.-M., Godefroy, O., Chillon, J.-M., Choukroun, G., & Massy, Z. A. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050536 · Cited by 590
Cognitive Impairment Associated With Atrial Fibrillation: A Meta-analysis
Kalantarian, S., Stern, T. A., Mansour, M., & Ruskin, J. N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00007 · Cited by 425
The chemistry of Alzheimer’s disease
Rauk, A. (2009) · Chemical Society Reviews · doi:10.1039/b807980n · Cited by 417
Promising Strategies for the Prevention of Dementia
Middleton, L. E., & Yaffe, K. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.201 · Cited by 396
Metadata
- Authors
- Hanon, O.
- Venue
- Vascular Health and Risk Management
- Publisher
- Informa UK Limited
- Published
- 2008-04
- Volume
- Volume 4
- Issue
- 2
- Pages
- 363-381
- ISSN
- 1176-6344 (ISSN-L)
- 1178-2048
- OpenAlex
- W1834345112
- Cited by
- 313
- References
- 218
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.